Compare TARA & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TARA | LEE |
|---|---|---|
| Founded | N/A | 1890 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Newspapers/Magazines |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.6M | 169.6M |
| IPO Year | 2014 | 2025 |
| Metric | TARA | LEE |
|---|---|---|
| Price | $2.30 | $6.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $25.33 | N/A |
| AVG Volume (30 Days) | ★ 852.9K | 27.0K |
| Earning Date | 11-06-2026 | 11-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.25 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,948,000.00 | ★ $543,955,000.00 |
| Revenue This Year | N/A | $4.44 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.09 | $3.34 |
| 52 Week High | $7.82 | $11.88 |
| Indicator | TARA | LEE |
|---|---|---|
| Relative Strength Index (RSI) | 42.02 | 47.18 |
| Support Level | $2.19 | $5.82 |
| Resistance Level | $2.73 | $6.65 |
| Average True Range (ATR) | 0.21 | 0.50 |
| MACD | 0.03 | 0.09 |
| Stochastic Oscillator | 34.43 | 40.83 |
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.
Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.